within Pharmacolibrary.Drugs.ATC.N;

model N05AL07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 2e-06,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0014,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.012583333333333334,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05AL07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Levosulpiride is a substituted benzamide antipsychotic and prokinetic agent that acts as a selective dopamine D2 receptor antagonist. It is used primarily in the treatment of psychiatric disorders such as schizophrenia, depression, and somatoform disorders, as well as gastrointestinal motility disorders like dyspepsia and gastroparesis. While it is not approved in the United States, it is used in several countries including India and Italy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following a single oral 25 mg dose.</p><h4>References</h4><ol><li><p>Arif, ST, et al., &amp; Zeb, A (2022). Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers. <i>Pharmaceutics</i> 14(11) –. DOI:<a href=\"https://doi.org/10.3390/pharmaceutics14112347\">10.3390/pharmaceutics14112347</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36365165/\">https://pubmed.ncbi.nlm.nih.gov/36365165</a></p></li><li><p>Cho, HY, et al., &amp; Lee, YB (2004). Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers. <i>International journal of clinical pharmacology and therapeutics</i> 42(3) 174–180. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15049438/\">https://pubmed.ncbi.nlm.nih.gov/15049438</a></p></li><li><p>Łebkowska-Wieruszewska, B, et al., &amp; Giorgi, M (2019). Pharmacokinetics of levosulpiride after single-dose administration in goats (Capra hircus) by different routes of administration. <i>Journal of veterinary pharmacology and therapeutics</i> 42(4) 440–446. DOI:<a href=\"https://doi.org/10.1111/jvp.12786\">10.1111/jvp.12786</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31206720/\">https://pubmed.ncbi.nlm.nih.gov/31206720</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05AL07;
